Oxford vaccine to cost Rs 200 per dose in India
The Covishield vaccine manufactured by the Serum Institute of India (SII) will be priced at ? 200 a vial after a price agreement was arrived at with the government, sources have said.
The first 100 million doses will be priced ? 200, say SII sources, and the initial tranche to be supplied is expected to be 11 million doses, reports NDTV.
The drug is expected to roll out of SII's Pune facilities tonight or tomorrow morning.
"The price is fixed in writing,'' said sources in the SII adding that exports of the life-saving vaccine are expected after January 16 as well.
"A few million doses of Covishield will be supplied every week. 11 million doses may be supplied in the initial lot," they added.
The process of administering the vaccine will start on on January 16, the government said on the weekend.
The SII vaccine developed by Oxford-AstraZeneca was cleared for emergency use along with Bharat Biotech's indigenous "Covaxin" earlier this month.